Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/7/2026

Hematuria and Proteinuria Evaluation

Introduction to Causes

  • The combination of hematuria and proteinuria most commonly indicates glomerular disease, particularly when proteinuria exceeds 1,000 mg per 24 hours or when accompanied by dysmorphic red blood cells (>80%) or red cell casts, according to the American College of Physicians 1, 2

Primary Glomerular Causes

  • Post-infectious glomerulonephritis and IgA nephropathy are common primary glomerular diseases presenting with this combination, as stated by the American Academy of Family Physicians 2
  • Alport syndrome (hereditary nephritis with associated hearing loss) should be considered, especially with family history, as recommended by the National Kidney Foundation 2
  • Lupus nephritis and vasculitis can cause both findings simultaneously, according to the American College of Rheumatology 2
  • Thin basement membrane nephropathy represents a common benign familial cause of persistent microscopic hematuria, as noted by the American Society of Nephrology 2

Systemic Diseases Causing Both Findings

  • Diabetes mellitus causes proteinuria through diabetic nephropathy and may have concurrent hematuria from other urologic causes, as stated by the American Diabetes Association 3
  • HIV-associated nephropathy (HIVAN) causes both proteinuria and hematuria, particularly in African American patients with advanced disease, according to the Centers for Disease Control and Prevention 3

Urologic Causes of Hematuria

  • Bladder cancer (transitional cell carcinoma) is the most frequently diagnosed malignancy in hematuria evaluation, as reported by the American Urological Association 2
  • Renal cell carcinoma and prostate cancer can cause hematuria, according to the National Comprehensive Cancer Network 2

Diagnostic Approach

  • Verify ≥3 RBCs per high-power field on microscopic examination and obtain 24-hour urine collection or spot protein-to-creatinine ratio to confirm true hematuria and quantify proteinuria, as recommended by the American College of Physicians 1, 4
  • Look for dysmorphic RBCs (>80% suggests glomerular origin) and identify red cell casts (pathognomonic for glomerular disease) to determine the source of hematuria, according to the National Kidney Foundation 1, 2

Age-Specific and Population-Specific Considerations

  • In patients with chronic kidney disease, African American persons, patients with diabetes, hypertension, or hepatitis C coinfection are at higher risk for proteinuria and poor renal outcomes, as stated by the National Institute of Diabetes and Digestive and Kidney Diseases 3
  • HIV-infected patients with CD4+ counts <200 cells/mL or HIV RNA ≥14,000 copies/mL require annual screening for proteinuria and hematuria, according to the Centers for Disease Control and Prevention 3

Common Pitfalls to Avoid

  • Never attribute significant proteinuria solely to hematuria without quantification—dipstick readings are misleading and must be confirmed with 24-hour collection, as recommended by the American College of Physicians 1
  • Do not dismiss the combination of hematuria and proteinuria as benign—this strongly suggests underlying glomerular disease requiring nephrology evaluation, according to the National Kidney Foundation 1

Evaluation of Hematuria and Proteinuria in Suspected Nephrolithiasis

Confirmation of Microscopic Hematuria

  • True microscopic hematuria should be confirmed by finding ≥ 3 red blood cells per high‑power field (RBCs/HPF) on at least two of three properly collected urine specimens before initiating an extensive work‑up. 5

Urinalysis Features Suggestive of Glomerular Disease

  • The presence of ≥ 80 % dysmorphic RBCs or red‑cell casts on microscopic urinalysis indicates a glomerular source of bleeding and warrants immediate nephrology referral. 5
  • Bilirubin detection in urine is atypical for uncomplicated kidney stones and should prompt evaluation for hemolysis, hepatic disease, or biliary obstruction. 6

Laboratory Evaluation to Distinguish Stone‑Related vs Glomerular Causes

  • Order a spot urine protein‑to‑creatinine ratio; values > 0.5 g/g strongly suggest renal parenchymal (glomerular) disease rather than stone‑related proteinuria. (Evidence level not specified).
  • Measure serum creatinine to assess baseline renal function when hematuria is identified. [5][7]
  • If microscopic analysis shows normal‑shaped RBCs with minimal proteinuria, a urologic work‑up for stones is appropriate. 5

Clinical Significance of Hematuria in Nephrolithiasis

  • Hematuria is the hallmark sign of kidney stones, occurring in the majority of patients presenting with acute renal colic. 7
  • Mild proteinuria may accompany stone passage due to transient tubular injury. 7

Metabolic Evaluation When Stones Are Confirmed

  • Perform a 24‑hour urine collection (calcium, oxalate, phosphate, uric acid, citrate, sodium, creatinine) to identify metabolic abnormalities that predispose to stone formation. 7
  • Hypercalciuria is the most common metabolic disorder associated with calcium‑based stones. (Evidence level not specified).

Referral Thresholds for Nephrology

  • Nephrology referral is indicated when any of the following are present:

All facts are derived from peer‑reviewed sources and reflect current clinical guidance.